Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Oxygenation in Gastric Endoscopy
NCT05723627Completed
- Sponsor
- Yonsei University
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam (2 arms), sponsored by Yonsei University. Primary endpoint: Incidence of Oxygen Reserve Index (ORI) drop to 0.00 during sedation. Started Apr 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05723627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723627.